Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.
The Hindu
Sun Pharma settles litigation with Incyte, gains license for alopecia treatment, launches LEQSELVI tablet in the US.
More Related News

Central Silk Board has an ambitious target of doubling the country’s silk value chain, currently pegged at ₹55,000 crore, by 2030, said P. Sivakumar, Member Secretary, Central Silk Board, a body that works under the Ministry of Textiles and is responsible for the overall development of the country’s sericulture.












